Ruth Luthi-Carter, PhD
Professor of Neurobiology of Behaviour at University of Leicester
Research Fellow at AC Immune SA
Location: Leicester
United Kingdom
Ruth Luthi-Carter, PhD, started her independent research group in 2003 at the Swiss Federal Institute of Technology (EPFL) in Switzerland and in 2012 became a full professor at the University of Leicester. Her research group has undertaken groundbreaking work to discover new potential therapeutic targets for brain diseases. She recently joined AC Immune SA as Research Fellow, bringing her molecular neurobiology expertise to the company's translational research.
Dr. Luthi-Carter earned her doctorate in pharmacology and molecular sciences from Johns Hopkins University, where she worked with Professor Joseph Coyle to uncover FOLH1 as the gene encoding an enzyme that subsequently became a therapeutic target for brain diseases and injury. She subsequently undertook postdoctoral research with Professor Anne Young at Harvard’s MassGeneral Institute for Neurodegenerative Disease.
Associated Grants
-
Development of Novel Brain-penetrant Inflammasome Inhibitors as Potential Therapeutics for Parkinson’s Disease
2021
-
Development of a Small-molecule Inhibitor Targeting Intracellular Alpha-synuclein Pathology
2021
-
-
Enhancing Mitochondria Quality Control in Parkinson’s via Activation of the Caseinolytic Peptidase
2015